Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2102-2014

Terumo Dual-stage Venous Return Cannulae 28/38, 29/37, 32/40, 34/46, 36/46 & 36/51 Fr with 1/2" flare or connector Product Usage: Venous Return Cannula is indicated for venous drainage during cardiopulmonary bypass surgery for dual cannulation of the superior and inferior vena cava

Publicado el 30 de julio de 2014 · Inicio del retiro: 23 de mayo de 2014

Resumen

FDA registra el retiro Z-2102-2014 de dispositivos médicos de Clase II, publicado el 30 de julio de 2014 e iniciado el 23 de mayo de 2014. Empresa responsable: Terumo Cardiovascular Systems Corporation; Estado: Finalizado; Cantidad reportada: 34,470 units; Lote: Part No. 813580, Lot #: AM004245, AM006060, AM016524; Part No. 813579, Lot #: AM001313, AM007311, AM007721, AM009067, AM016176, AM016523, AM018165; Part No. 813582, Lot #: AM001293, AM017320; Part No. 813581, Lot #: AM002694, AM003543, AM006059, AM017959; Part No. 813584, Lot #: AM001311, AM002688, AM002730, AM006055, AM016188, AM016639; Part No. 813583, Lot #: AM002729, AM006054, AM016187, AM016638, AM018071; Part No. 813586, Lot #: AM001303, AM005726, AM006061, AM008349; Part No. 813585, Lot #: AM002473, AM002728, AM006056, AM010935, AM017208; Part No. 813588, Lot #: AM002690, AM002699, AM003781, AM004252, AM006058, AM008238, AM016477; Part No. 813587, Lot #: AM001314, AM002687, AM003782, AM006057, AM008237, AM016189, AM016476, AM018297; Part No. 813590, Lot #: AM016920 & Part No. 813589, Lot #: AM002720, AM004287. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

During an in-process inspection, Terumo Cardiovascular Systems (Terumo CVS) identified the presence of loose fiber particulate that exceeded finished product specifications

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Terumo Cardiovascular Systems Corporation
Distribuidor
Worldwide Distribution - US (nationwide) in the states of: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV & WY and the countries of : Australia, Belgium, Canada, Chile, Japan, Malaysia, Mexico, Singapore, Taiwan, Thailand, United Arab Emirates (UAE) & United Kingdom.
Lote
Part No. 813580, Lot #: AM004245, AM006060, AM016524; Part No. 813579, Lot #: AM001313, AM007311, AM007721, AM009067, AM016176, AM016523, AM018165; Part No. 813582, Lot #: AM001293, AM017320; Part No. 813581, Lot #: AM002694, AM003543, AM006059, AM017959; Part No. 813584, Lot #: AM001311, AM002688, AM002730, AM006055, AM016188, AM016639; Part No. 813583, Lot #: AM002729, AM006054, AM016187, AM016638, AM018071; Part No. 813586, Lot #: AM001303, AM005726, AM006061, AM008349; Part No. 813585, Lot #: AM002473, AM002728, AM006056, AM010935, AM017208; Part No. 813588, Lot #: AM002690, AM002699, AM003781, AM004252, AM006058, AM008238, AM016477; Part No. 813587, Lot #: AM001314, AM002687, AM003782, AM006057, AM008237, AM016189, AM016476, AM018297; Part No. 813590, Lot #: AM016920 & Part No. 813589, Lot #: AM002720, AM004287.
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Terumo Dual-stage Venous Return Cannulae 28/38, 29/37, 32/40, 34/46, 36/46 & 36/51 Fr with 1/2" flare or connector Product Usage: Venous Return Cannula is indicated for venous drainage during cardiopulmonary bypass surgery for dual cannulation of the superior and inferior vena cava fue retirado del mercado?

Sí. FDA publicó el retiro Z-2102-2014 el 30 de julio de 2014. Peligro reportado: During an in-process inspection, Terumo Cardiovascular Systems (Terumo CVS) identified the presence of loose fiber particulate that exceeded finished product specifications

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter